Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,928.45
-54.25 (-2.74%)
At close: Oct 28, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 489.78 billion as of October 28, 2026. Its market cap has increased by 48.73% in one year.
Market Cap
489.78B
Enterprise Value
500.51B
Revenue
101.26B
Global Rank
n/a
Country Rank
n/a
PE Ratio
37.35
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 489.78B, an increase of 15,116.34%. That is a compound annual growth rate of 22.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 489.78B | 36.06% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.09T |
| Mankind Pharma | 954.85B |
| Aurobindo Pharma | 914.85B |
| Glenmark Pharmaceuticals | 628.12B |
| Alkem Laboratories | 601.41B |
| Ipca Laboratories | 491.83B |
| Gland Pharma | 469.15B |
| Ajanta Pharma | 422.41B |